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Abstract 
Osteopenia of prematurity is a metabolic bone disease affecting neonates born during the 
second trimester of pregnancy and classified as very low birth weight, or less than 1500 grams at 
birth.  Improvements in neonatal nutrition have reduced osteopenia of prematurity by increasing 
available calcium, phosphorus, magnesium and vitamin D for bone mineralization.  Ossification 
also requires the presence of adequate bone matrix for mineralization to be completed.  Passive 
mechanical stimulation such as joint compression replicates the resistance and weight bearing 
movements of the fetus in utero.  Fetal osteoprogenitor cells are signaled to develop into 
osteoblasts, thus creating bone matrix which can then be mineralized.  Research into the effects of 
passive physical exercise with joint compression on the prevention of osteopenia of prematurity are 
compared and discussed to ascertain recommendations for future implementation and 
considerations. 
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 Almost 65,000 neonates are born each year with birth weights less than 1500 grams, 
qualifying them as very low birth weight (VLBW) infants.  In the vast majority of cases, VLBW 
designation also corresponds to a gestational birth age of less than 32 weeks (Hamilton, Martin, & 
Ventura, 2010).  Among the many potential consequences is osteopenia of prematurity (OOP), 
which affects approximately 30% of premature, VLBW neonates (Cross & Vasquez, 2009). 
 OOP is described as a loss of bone density resulting from suboptimal bone mineralization 
(Lam, So, & Ng, 2007).  OOP should not be considered expected sequelae of VLBW birth, nor is it 
without its own consequences.  OOP can produce soft, unstable bones unsuitable for maintaining 
normal physical structure.  In particular, a neonate with severe chronic lung disease may not have 
the structural strength of the ribs to keep the chest wall from pressing down onto the lungs, making 
it even more difficult to wean off a ventilator (Williford, Pare, & Carlson, 2008).  An osteopenic 
neonate is susceptible to fractures with normal handling during routine care.  The neonate can 
sustain loss of function and pain from the fractures (Williford, Pare, & Carlson, 2008).  OOP 
negatively impacts neonatal growth rate (Mitchell, Rogers, Hicks, Hawthorne, Parker, & Abrams, 
2009).  Severe OOP with alkaline phosphotase levels > 1200 IU/ml have been associated with 
reduced linear growth at 18 months of age (Demarini, 2005). 
Normal Physiology Related to Term Gestation 
Fetal ossification of strong, stable bones is strongly influenced by movement (Lam, So, & 
Ng, 2007).  Bone structure follows function, and a variety of stressors from joint impact (weight 
bearing) to mechanical pull increases both length and cortical thickness (So & Ng, 2005). By the 
end of the second trimester (approximately 28 weeks gestation), the fetus can move up to thirty 
times per hour (Nihira, 2009).  The muscular walls of the uterus acts as resistance to provide 
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weight-bearing experiences for the fetus as the arms and legs extend, then recoil back to flexed 
positions.  In addition, the mother moves and changes positions throughout the day.  This activity 
changes the plane of movement for the fetus, creating differing mechanical strains on muscles 
(Land & Schoenau, 2008). 
 Physical activity and weight bearing/resistance movement signals bone-forming cells called 
osteoblasts to secrete bone matrix according to areas being stressed by function.  Once surrounded 
by matrix, osteoblasts are considered mature bone cells, or osteocytes.  The final step of stable bone 
formation is mineralization via deposition of calcium, phosphorus and magnesium (Rauch & 
Schoenau, 2002).  Mineralization depends on proper nutritional intake, gastrointestinal absorption 
into the bloodstream, and presence of vitamin D to assist the regulation of these processes 
(Demarini, 2005). 
The fetus is dependent upon the mother for all nutrients throughout the pregnancy.  
Beginning in the second trimester, an increasing amount of calcium crosses the placenta and enters 
fetal circulation (Rauch & Schoenau, 2002).  However, the vast majority of mineral exchange 
occurs in the third trimester, peaking at 36-38 weeks gestation (Williford, Pare, & Carlson, 2008). 
At this point, large amounts of calcium are flowing into the fetus creating fetal serum calcium levels 
approximately five times higher than maternal serum calcium levels. 
Fetal serum phosphorus levels also increase in the third trimester (Cross & Vasquez, 2009).  
During this time, the fetus is actively mineralizing strong, stable bones as well as storing extra 
calcium and phosphorus in the bones.  This is necessary biologically as the maternal-to-fetal 
hypercalcemic circulation is abruptly halted at delivery when the umbilical cord is cut (Land & 
Schoenau, 2008).   
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 After birth the term newborn ingests very little at breast for the first two or three days.  
Thereafter, maternal breastmilk contains much less calcium than the rich blood supply in utero.  It is 
during this time the extra mineral stores are slowly released from the bones to maintain adequate 
serum levels (Williford, Pare, & Carlson, 2008).  Specifically, low serum calcium levels trigger the 
release of parathyroid hormone (PTH).  PTH signals another type of bone cell, the osteoclast, to 
release calcium into the bloodstream by breaking down or “remodeling” areas of bone (Land & 
Schoenau, 2008). 
Pathophysiology Related to Preterm, VLBW Neonates 
 The greatest risk of OOP for the VLBW neonate results from the lack of mineral store 
deposition during the third trimester (Eliakim & Nemet, 2005).  Lacking exposure to the calcium-
rich maternal/placental circulation, the premature infant begins life at a distinct disadvantage:  
Though typical for gestational age, the VLBW neonate has relatively unstable bones.  In addition, 
the neonate has little in the way of extra calcium and phosphorus stores from which to draw in order 
to meet the needs of bone mineralization (So & Ng, 2005). 
 A preterm, VLBW neonate faces a host of other contributing factors which can increase the 
risk and severity of OOP.  The VLBW neonate is not likely to tolerate full enteral feedings within 
the first week of life.  Intravenous nutrition in the form of total parenteral nutrition (TPN) is 
minimally capable of supplying optimal daily intake of calcium and phosphorus (So & Ng, 2005).  
Even centrally infusing TPN cannot deliver the daily recommended amounts of minerals for VLBW 
neonates.  Reasons vary and include limits on calcium:phosphorus solubility (Lam, So, & Ng, 
2007).   
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Almost all VLBW neonates are treated with fluid restrictions which further limit the mineral 
inclusion in the TPN recipe (So & Ng, 2005).  This factor becomes more pronounced if IV access is 
peripheral only.  Many NICUs do not infuse calcium peripherally.  An NICU which opts to infuse 
calcium peripherally should do so in small amounts to minimize risk of infiltration-associated tissue 
sloughing (Abrams, 2008). A provider would still be unable to administer enough to meet the 
neonate’s daily needs. 
A VLBW neonate is at higher risk to remain on TPN for a prolonged period of time.  
Reasons include feeding intolerance of unknown etiology, intestinal dysmotility, septicemia 
requiring a hold on enteral feeds, and/or necrotizing enterocolitis (So & Ng, 2005).  The optimal 
solution is a transition to enteral feedings as soon as possible (Cross & Vasquez, 2009).  
Appropriate enteral feedings consist of breastmilk fortified with a powder additive delivering 
additional calcium, phosphorus and calories equally 24 calories per ounce.  A formula alternative 
would be a specialized premature infant formula containing higher levels of calcium and 
phosphorus, also providing 24 calories per ounce (Eliakim & Nemet, 2005).   Unfortunately, some 
VLBW neonates do not initially tolerate fortified, higher-calorie feedings.  Unfortified breastmilk 
and premature formula do not provide the requisite amount of mineral intake (So & Ng, 2008). 
Routinely prescribed medications can negatively affect the neonate’s ability to properly 
mineralize bone matrix.  Furosemide is known to cause hypercalcuria and nephrocalcinosis.  
Furosemide signals the kidneys to filter calcium out of the bloodstream and excrete it (Cross & 
Vasquez, 2009).  As the serum calcium level drops, PTH rises and osteoclasts begin to remodel 
bone to maintain serum calcium levels.  Methylxanthines and glucocorticoids are also implicated as 
risk factors for the development of OOP (So & Ng, 2005). 
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One of the most overlooked contributing factors of OOP is physical movement.  As part of 
neonatal developmental care, a significant effort has been made to promote flexion-predominant 
positioning, boundaries, and a “hands-off” approach towards neonatal care (Eliakim & Nemet, 
2005).  In reality, neonates in utero are exposed to muffled noises, shades of light, exterior 
movement from the mother, and self-movement within a tactile environment.   
After birth, the VLBW neonate is no longer able to move freely within a buoyant 
environment, experiencing positional changes as the mother goes about daily life.  The VLBW 
neonate is subjected to the forces of gravity in the NICU (Demarini, 2005).  Instead of free-floating, 
weight-bearing extension/flexion, the neonate experiences restricted movement via gravitational 
pull (Rauch & Schoenau, 2002).  Indeed, this difference between in utero and ex utero movement 
diminishes the VLBW neonate’s ability to engage the body’s system of function/structure 
ossification (Land & Schoenau, 2008).  A decrease in function decreases osteoblast activity, thus 
creating less osteiod structure to mineralize even if optimal calcium, phosphorus, magnesium and 
vitamin D intake are provided (Rauch & Schoenau, 2002).  Physical exercise programs including 
joint compression are specifically designed to re-engage the function/structure ossification process 
of VLBW neonates. 
Diagnosis of OOP 
Among the difficulties in treating OOP is the lack of a single accepted definition.  In 
general, OOP is diagnosed by lab values including serum phosphorus of < 3.5-4 (Cross & Vasquez, 
2009) and elevated alkaline phosphotase (alk phos) at five times the normal adult levels (Rauch & 
Schoenau, 2002), or > 650-800, depending on sources.  Interestingly, high alk phos levels correlate 
poorly to high degrees of hypo-mineralization (So & Ng, 2005; Mitchell et al, 2009). Much 
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controversy surrounds typical lab values currently utilized to measure nutrition status and degree, or 
risk of OOP.  For example, some sources quote a serum phosphorus < 4.5 mg/dL as diagnostic 
(Land & Schoenau, 2008).   
 Many NICU guidelines suggest following serum calcium levels, although these results 
actually have little value.  Activation of PTH assures normal serum calcium in all but the most 
severe hypocalcemic states (Cross & Vasquez, 2009).  More telling are ionized calcium (iCa) levels, 
as iCa reflects the biologically available calcium in the blood.  Concerning iCa levels would be < 1 
mmol/L (Abrams, 2008).   
Standard radiographs are also used in the detection of OOP.  Bone demineralization can be 
visualized as a haziness or milky quality of the long bones and ribs on x-ray.  Unfortunately this is a 
late sign of OOP.  A neonate has to lose 30-40% of bone mineralization before it is apparent on 
standard radiographs (Lam, So, & Ng, 2007; Eliakim & Nemet, 2005).  Often the first 
radiographical sign is a fracture; a hairline fracture of a rib or long bone, or a cross-sectional 
fracture.  This represents advanced OOP. 
Literature Review 
Much of the current knowledge and protocols are based on the seminal research report 
published by Moyer-Mileur, Luetkemeier, Boomer, and Chan in the October 1995 issue of The 
Journal of Pediatrics.  Moyer-Mileur set the stage for subsequent research into physical exercise 
routines for VLBW neonates.  The Moyer-Mileur protocol consists of passive range-of-motion and 
gentle joint compression movements to the six large joints of the extremities for the experimental or 
exercise (EX) groups.  This encompasses the shoulder, elbow, wrist, hip, knee, and ankle.  The 
control groups (C) receive a commensurate amount of time being held and stroked but not 
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exercised.  The purpose is to neutralize any advantage of positive touch by assuring all neonates 
receive soothing touch during the entirety of the study. 
Eligibility for the original Moyer-Mileur study included 1) corrected gestational age (CGA) 
of 26-34 weeks, 2) body size and weight deemed appropriate for gestational age (AGA), 3) enteral 
feedings at > 110 kcal/kg/day, 4) intake of no medications other than vitamin supplements, and 5) 
parental consent.  Each group of neonates received the prescribed treatment activity for 5-10 
minutes per day for four weeks.  All neonates were fed either breastmilk with Enfamil Human Milk 
Fortifier 24 cal/oz, or Enfamil Premature Formula 24 cal/oz. A total of 13 neonates completed the 
study in each group (exercise and control).  Groups were matched for birth weight, gender, and 
gestational age, and were randomly placed in either the exercise or control group. Baseline and 4-
week assessments were collected for the study. 
Standard growth parameters such as weight, length and head circumference (OFC) were 
collected.  Lab studies included routine nutritional levels (calcium, phosphate, alk phos) in addition 
to PTH and vitamin D levels.  Bone characteristics were measured via single-beam photon 
absorptiometry.  Data was analyzed using descriptive statistics, independent t-Test, ANOVA, and 
correlation and linear regression.  A synopsis of the original Moyer-Mileur results includes: 
1. Similar nutritional intakes between groups appropriate for gestational age 
2. Statistically significant greater daily weight gain by the EX group as compared to the 
C group (17.8 vs. 13.4 gr/kg/day, p = 0.01) 
3. EX group:  12% gain in bone width, 18% gain in bone mineral density, 34% gain in 
bone mineral content over the course of the study 
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4. C group:  2% gain in bone width, 17% loss in bone mineral density, 11% loss in 
bone mineral content over the course of the study 
5. Biochemical markers similar except for alkaline phosphotase which was lower in EX 
group vs. C group at the end of the study (72 + 21 vs. 122 + 29 U/L; 
 p = <0.001); results for all groups within normal ranges 
6. Negative association between bone mineral content and PTH values; r = -0.83, 
  p = 0.01 
7. Conclusions:  exercise  program for healthy preterm infants may promote positive 
weight gain and increased bone mass 
Since the original study, Moyer-Mileur and others have repeated studies in the effort to 
replicate, support, and expand on the original findings.   
Joint compression and range-of-motion as exercise therapies (Table 1) 
Moyer-Mileur, Brunstetter, McNaught, Gill, and Chan (2000) studied 32 neonates 
comparing range-of-motion (ROM) and joint compression (JC) as exercise regimens against 
positive touch and the effects of each intervention on bone mineralization and growth.  Aly et al 
(2004) took a somewhat different approach in adding short periods of massage therapy to the 
exercise group, and removing the purposeful positive touch from the control group.   
Moyer-Mileur et al (2000) was the first to utilize a DEXA scanner to determine bone 
mineral density and content in premature neonates.  With 16 neonates in each group matched for 
gestational age and birth weight, each randomly assigned to either the EX and to the C group.  In 
addition to the standard measurements of growth parameters, other indices of bone mass were 
collected.  The biomarker of bone formation for this study was serum type I collagen C-terminal 
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propeptide (PICP):  The biomarker for bone resorption was urine pyridinoline cross-links of 
collagen (Pyd).  Additionally, standard nutritional lab values for VLBW neonates were obtained as 
well as PTH levels.  All measurements were made at the beginning of the study and again when 
each neonate reached two kilograms (2 kg) in weight. Study eligibility included 1) birth weight 800-
1600 grams, 2) GA 26-32 weeks, 3) AGA, 4) tolerating enteral feeds of  >110 kcal/kg/day, 5) no 
medications other than vitamin supplements, and 5) parental consent.  All neonates were fed either 
breastmilk with Enfamil Human Milk Fortifier 24 cal/oz or Enfamil Premature Formula 24 cal/oz. 
Data analysis utilized descriptive statistics, independent t-Test, ANCOVA, and correlation 
and linear regression.  Ad hoc data comparison was analyzed in four stages including birth to study 
entry, study entry to 1.5 kg, 1.5-1.8 kg, and 1.8-2 kg.  The purpose was to delineate if other factors 
such as catch-up growth were the main reasons behind weight increases as opposed to the study 
exercise regimens. A synopsis of the study results includes: 
1. Similar body measurement throughout the study. 
2. The EX group demonstrated greater daily weight gain from study entry to 2 kg 
compare to C group (16.3 + 2.6 vs. 14.6 + 2 gr/kg/d, p < 0.02).   
3. EX group had greater forearm length, bone area, and bone mineral content at 2 kg (p 
= < 0.05, t-test).   
4. Serum chemistry results were comparable.  Pyd levels did not change in either group. 
5. EX group experienced a stable PICP while the C group experienced a significant 
decrease in PICP (between-groups p = 0.05, ANCOVA). 
6. Conclusions suggest a lower rate of bone mineralization in the C group, thus 
supporting neonatal physical exercise programs for VLBW neonates who are stable 
on excellent nutrition.   
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Aly et al (2004) also considered physical exercise with the combination of JC/ROM to be 
superior.  In addition, his study added five minutes of massage to the EX group.  The C group did 
not receive anything specific for this study.  This double-blinded randomized trial included 30 
neonates, 15 in each group.  Inclusion criteria were 1) GA < 35 weeks, 2) post-natal age < 2 weeks, 
3) tolerating full enteral feeds, 4) no medications other than vitamin supplements, and 5) parental 
consent.  Exclusion criteria included congenital malformations, asphyxia, or musculoskeletal, liver, 
or renal diseases.  The EX group received five repetitions of JC/ROM on each extremity per the 
Moyer-Mileur design plus another five minutes of massage.  The intervention routine was 
performed once each day by the same physician from study entry until attainment of 1.8 kg.   
Growth parameters, standard nutritional labs, and PTH levels were followed.  Bone 
biomarkers included serum PICP and urine Pyd.  All information was documented at study entry 
and at 1.8 kg.  Data analysis methods included t-Test, ANOVA, and linear regression.  A synopsis 
of the study results includes: 
1. No difference in GA or birth weight between groups 
2. Over time, urine Pyd increased for both groups with the results having no statistical 
significance.   
3. EX group serum PICP increased while C group serum PICP decreased (statistically 
significantly, p = 0.0001). 
4. Serum alk phos levels did not change significantly between the groups.   
5. Conclusions indicate increased bone mineralization among EX group neonates 
receiving JC, ROM, and massage compared to C group neonates receiving no 
specified touch. 
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Range-of-motion only as exercise (Table 2) 
ROM-only has been utilized as the basis for two studies whose purpose was to test the effect 
of length of treatment.  Litmanovitz et al (2003) researched the effects of ROM vs. positive touch 
on bone strength of VLBW neonates.  The study compared extremity ROM five days per week for 
four weeks vs. positive touch of the same duration.  Each group consisted of 12 neonates meeting 
the eligibility criteria of 1) birth weight < 1500 grams, 2) AGA, 3) postnatal age < 1week, and 4)  
parental consent.  This study excluded neonate with major congenital anomalies, severe central 
nervous system disorders, or intrauterine growth retardation.  Of note, this is one of the first studies 
to consider exercise in the first week of life regardless of enteral feeding status or medications 
prescribed.   
Participant information was tracked for age, weight, feeding status, and oxygen needs.  
Specific markers of bone strength for this study included bone-specific alkaline phosphates (BSAP, 
same as BALP).  Bone resorption was tested with serum carboxy terminal cross-links telopeptide of 
type-I collagen (ICTP), which reflects osteoclast activity.  Lastly, bone mineralization was 
measured using Quantitative Ultrasound (QUS) to assess the Speed of Sound (SOS) through the left 
tibia.  Statistical analysis was completed utilizing unpaired t-Test and 2-way repeated measures 
ANOVA with level of significance set at P < 0.05.  A synopsis of the study results includes: 
1. No difference in birth weight, GA, gender, ethnicity, morbidities, or days to full 
enteral feedings.   
2. No significant differences at the beginning of the study in the body measurements or 
tibial SOS.   
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3. Differences in bone growth of both groups during the study were not statistically 
significant. 
4. Tibial SOS remained steady in the EX group but decreased in the C group 
significantly (p < 0.006).   
5. Both groups experienced increases in BSAP with concurrent decreases in ICTP; 
intergroup differences were not significant.  
6.  Conclusions suggest an attenuation of decreased bone SOS in VLBW neonates.   
This study did not demonstrate increased bone health benefits of previous studies. Possible rationale 
include the use of a newer bone measuring device (QUS-SOS) which considers factors such as bone 
elasticity in its calculations. Another difference was the inclusion of VLBW neonates who were not 
yet on enteral feeds or who were still receiving medications which potentially interfered with 
calcium deposition in the bones. Lastly, joint compression was not utilized as an intervention. 
As a follow-up, Litmanovitz, Dolfin, Arnon, Regev, Nemet, and Eliakim (2006) replicated 
the Litmanovitz et al (2003) study in its entirety with the exception of lengthening the intervention 
to eight weeks in duration.  The purpose was to determine an optimal duration of an exercise 
program.  Inclusion/exclusion criteria, statistical analysis, and measurements of bone 
strength/turnover were unchanged from the previous study.  The EX and C groups had eight 
participants each.  Characteristics of the participants in each group were matched and without 
statistical differences.  A synopsis of the study results includes: 
1. Increase in EX group tibial SOS with corresponding decrease in C group tibial 
SOS (between-group difference P = 0.01) 
2. Most of the tibial SOS change in both groups occurred in the first four weeks  
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3. Less dramatic changes in tibial SOS continued to occur throughout the second 
four weeks 
4. Unable to document positive effects on weight gain when exercise regimen is 
started early in life 
5. Tibial SOS stability in EX group occurred without significant gains in weight. 
6. Conclusions suggest a positive outcome from early exercise intervention, in this 
case stability of bone without growth gains. 
Possible rationale for lack of growth gains in this study includes the participation of VLBW 
neonates within the first week of life.  During this time, the VLBW neonate can be expected to lose 
10-15% of birth weight via extracellular water contraction.  Furthermore, VLBW neonates are 
usually under a fluid restriction, and must work up to full enteral feedings gradually (Cunningham, 
2009).  These factors may mask exercise-related weight gains during the first several weeks when 
VLBW neonates begin an exercise program during the first week of life.  Again, JC was not 
utilized. 
Range-of-motion only as exercise with maternal involvement (Table 3) 
 The final study took a different approach to testing neonatal exercise.  Moyer-Mileur, Ball, 
Brunstetter, and Chan (2008) tested the effects between EX participants with ROM delivered by the 
mother (MOM group), EX participants with ROM delivered by an occupational therapist (OT 
group), and C group participants receiving positive touch.  The purpose of the study was to 
determine if neonatal exercise could be safely and effectively provided by a parent.  Eligibility 
criteria included 1) gestational age 26-31 weeks, 2) AGA, 3), tolerant of feedings of fortified 
breastmilk > 110 kcal/kg/day, 4) no medications other than vitamin supplements, and 5) parental 
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consent.  EX group neonates received extremity (six joint) ROM from either the mother or an OT.   
C group neonates received five minutes per day of dedicated positive touch.  Eligible neonates were 
randomized into groups until there were 11 participants in each group.  Each participant was studied 
from entry into the study until attaining a body weight of 2 kg. 
 Data collection included the usual birth information and growth parameters along with 
nutritional data including serum lab studies of nutrition.  Biochemical bone markers included serum 
BSAP for bone formation and urine Pyd for bone resorption.  Bone strength measures were 
obtained utilizing a portable DEXA scanning of the right radius and ulna. Mothers involved in the 
study were taught ROM by the OT’s and also received weekly reviews.  Mothers maintained diaries 
to document the ROM sessions.  Data analysis included descriptive statistics, ANOVA, linear 
regressions, and the use of one-tailed significance of 0.05.  Data was collected at study entry and 
upon reaching 2 kg in weight. 
All groups were matched for age, birth weight, ethnicity and growth measurements.  Energy 
and dietary intake were similar, and number of exercise/touch session was equal among all groups.  
A synopsis of the study results includes: 
1. No difference in growth rate (gr/kg/d), head, or length measurements before or 
during the study period. 
2. BSAP remained constant for MOM and OT groups but was significantly lower in 
the C group by 2 kg of weight (P = 0.04) although all results were within normal 
limits. 
3. No differences in Pyd levels among groups. 
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4. At 2 kg, bone area of right forearm was greater in MOM and OT groups (P = 
0.03).  Size-adjusted gains for bone area and bone mineral content from baseline 
to 2 kg were significantly greater in the MOM and OT neonates 
 (P <0.001) vs. the C group neonates. 
5. Conclusions suggest effectiveness of maternal-mediated exercise programs 
within the VLBW population, and also reiterate the value of exercise on bone 
growth and mineral acquisition during the early weeks of postnatal life.  
Interpretations, Considerations, and Recommendations 
 A certain logic exists when considering the potential positive impact of exercise on bone 
development and strength.  A rational assumption is anything replicating movements and bone 
stressors of the in utero environment must be valid interventions for bone health of VLBW 
neonates.  Yet research thus far has not been overwhelmingly consistent in supporting these 
assumptions.    Several reasons can be considered, most of which pertain to lack of standardization 
in screening and diagnosis. 
 Lab studies are a weak area in the OOP arena.  Without a consensus as to what constitutes 
OOP, it is difficult to accurately interpret the current research.  PTH is becoming a common 
biomarker in research:  It is recommended to become a routine nutrition lab value for the VLBW 
neonate.  PTH levels are particularly valuable when serum calcium is monitored.  The PTH level 
informs the provider if the serum calcium is maintained secondary to increased bone resorption.  
Calcitonin is a hormone whose action is to impede bone resorption and renal filtration of calcium 
(Williford, Pare, & Carlson, 2008).  Calcitonin does not directly increase mineral deposition into 
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bone matrix; therefore this hormone level would of little value in the screening and management of 
OOP. 
Alkaline phosphotase is a commonly used diagnostic lab value.  Significant elevations are 
widely accepted as proof of OOP.  However, even an elevated alkaline phosphotase can be 
deceiving.  Alk phos is a total measure of three types of phosphotase; bone, liver, and intestinal.  A 
rise in any type can raise the total result.  Bone phosphotase is further separated into subtypes—one 
released when building bone and one released when remodeling bone—and can increase as a result 
of either bone mineralization or bone remodeling (Land & Schoenau, 2008).  Therefore, total alk 
phos can rise in response to bone mineralization, not just born resorption (Williford, Pare, & 
Carlson, 2008). A more sensitive measure is bone-specific alkaline phosphotase (BSAP or BALP).   
BALP is found on the surface of osteoblasts, and is released into the bloodstream during 
matrix formation (So & Ng, 2005).  Therefore, an elevated BALP in light of an elevated alk phos 
would point towards active bone building rather than bone remodeling and poor nutritional status as 
the reason for an elevated alk phos (Lam, So, & Ng, 2007).  It is recommended to add BALP levels 
when alk phos reaches the standard threshold for OOP. 
Standard testing parameters for research studies do not exist, again increasing the difficulty 
of determining the value and relevancy of the study conclusions.  Comparing study results based on 
calcium/PTH levels to study results based on PICD/Pyd levels is an exercise in futility.  The same 
holds true when comparing bone measurements by various instruments such as DEXA, pDXA, 
single-beam photo absorptiometry, standard radiograph, and QUS-SOS.  Each instrument measures 
somewhat different parameters.  And some experts question what “good bones” really mean to the 
VLBW neonate.  Does it mean heavy bones, as in high bone mineral density?  Or does is mean 
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stable bones, as in bone area and bone mineral content?  Again, no consensus exists to apply to the 
available studies or to current practice.  
Early studies showing the most benefits from exercise including joint compression were 
limited to healthy preterm neonates who were no longer dealing with other OOP risk factors (TPN, 
diuretics, corticosteroids, methylxanthines, feeding intolerance, etc).  Studies are now capturing the 
VLBW population at the very beginning of their lives in the NICU.  This may explain the 
seemingly “less convincing” results of late.  Or it could also signal a reduced impact of exercise so 
early in life.  It is these questions and others which require more focused research.  Multi-center 
double-blinded RCT’s with larger numbers of participants would lend more strength to the 
conclusions as well.  At the current time, it is recommended for NICUs to continue with the 
exercise/joint compression protocol already in place, as no study has documented negative 
participant effects secondary to the exercise protocol.  VLBW neonates should also receive at least 
400 IU of vitamin D daily to promote proper metabolism of calcium intake (Land & Schoenau, 
2008). 
Parental/family education and support 
In the spirit of informed consent, all parents of VLBW neonates should be informed of 
potential risks for their infants.  OOP is one of those risks.  Part of the discussion should include 
measures undertaken by the provider and NICU staff to minimize the OOP risk and/or treat OOP 
once diagnosed.  Discussing the side effects of OOP such as fractures is considered part of open 
family communication.  Offer parents up-to-date printed information to discuss with other support 
persons.  A quality website such as MedlinePlus at http://www.nlm.nih.gov/medlineplus offers 
families the ability to search osteopenia of prematurity and obtain information as well as 
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radiographical images of this disease.  OOP is just one of many concerns facing the VLBW neonate 
and their families.  Compassionate care and family counseling are often helpful in managing 
feelings of grief, negotiating cultural concerns, coping with financial worries, and identifying 
changes in family dynamics (Subramanian, Barton, & Muntazami, 2001).  Referring the parents to a 
unit-based social worker or parent advocate would be appropriate. 
Professional staff resources 
 Staff knowledge and expertise is exceedingly important in the care of the VLBW neonate 
and the family.  Professional staff in all roles has an abundance of resources to utilize.  An easy 
resource to access is online search engines; just spell out the disease name rather than using OOP.  
Searching for osteopenia of prematurity in Google Scholar brings up journal and research articles 
from the past 20-30 years. Providers can appreciate the historical perspective of the discovery and 
development of OOP as a disease entity.  Furthermore, NICU staff can access high-quality neonatal 
care reference books by editors/authors such as Fanaroff et al, MacDonald et al (Avery), Gomella et 
al, and Cloherty et al. 
Conclusions 
 Prematurely born infants face extended hospitalizations and risks of further medical 
problems.  These risks increase when the neonate is born during the second trimester and is of very 
low birth weight.  In particular, osteopenia of prematurity becomes a greater concern secondary to 
the neonate’s lack of exposure to the hypercalcemic circulation of the third trimester.  Solid strides 
have been made to lessen the occurrence and severity of OOP in the VLBW population.  Increased 
calcium and phosphorus intake is possible with the routine use of fortified breastmilk to 24 cal/oz 
and/or specialized 24 cal/oz premature formula.  Regular administration of vitamin D is an 
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emerging intervention in consideration of its role in calcium metabolism and bone mineralization.  
Patient management geared towards earlier enteral feedings is helpful, especially when one 
considers there was once a time in neonatal history when neonates were not enterally fed if an 
umbilical artery catheter was in place.   
The next significant step is sorting out the role of joint compression and other forms of 
exercise therapy.  The world of neonatology is constantly trying to “recreate the womb” in hopes of 
reducing morbidity and mortality.  The type and intensity of fetal movement in utero has yet to be 
replicated ex utero or solidly proven to be beneficial.  Range-of-motion only studies fail to consider 
weight-bearing movement in utero.  Large number, multi-center, double-blinded RCT’s are needed 
to assist in defining “normal” and “standard” in OOP assessment and management.  Only then will 
the neonatal community be able to develop best-practice standards and interventions.  Toward that 
goal, it need not be left to interested physicians, occupational therapists, and/or nutritionists to move 
forward.  As active, engaged team members in the primary care management of premature neonates, 
it is the rightful place and responsibility of today’s NNPs to lead research efforts in the prevention 
and management of osteopenia of prematurity. 
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Table 1 
AUTHOR (YEAR)  
JOURNAL 
STUDY LOCATION 
Moyer-Mileur, Brunstetter, McNaught, Gill, 
& Chan (2006) 
The Journal of Pediatrics 
University Hospital, Salt Lake City 
Aly, Moustafa, Hassanein, Massaro, Amer, 
& Patel, (2004) 
Journal of Perinatology 
Ain Shams University Hospital, Cairo 
DESIGN  
 
 
 
COHORT 
 
 
# OF SUBJECTS 
Randomized clinical trial; data collected 
until attainment of 2kg in weight  
(ave. 26.8 EX, and 23.8 C) 
BW: 80-1600 gr 
CGA:  26-32 wks 
Enteral fds: >110kcal/kg/d 
Meds: vitamins only 
n=16 each EX & C groups 
Prospective double-blinded randomized 
trial; data collected until attainment of 
1.8kg in weight  
CGA: 28-35 wks 
BW mean: 955g 
PNA: < 2wks 
Enteral fds: full 
Meds:  vitamins only 
n=15 each EX & C groups 
INTERVENTIONS  
OF STUDY 
EX group:  Joint compression & ROM to 
four extremities, 5 repetitions each 
movement daily  
C group: 5 minutes per day of 
holding/stroking 
EX group:  joint compression, ROM, 
massage x5 repetitions daily  
 
C group:  no focused tactile touch or 
intervention 
RESULTS EX group: 
-greater wt gain from start of study to 2kg 
in weight 
-greater forearm length, bone area, bone 
mineral content at 2kg 
-no change in PICP levels (bone 
deposition) whereas C group had 
decreasing PICP levels 
EX group: 
-increased and significantly higher PICP 
levels at end of study (bone deposition) 
-same alk phos/Pyd levels throughout 
(bone resorption) 
-increased PTH level compared to C group 
LIMITATIONS 
 
 
 
 
RECOMMENDATIONS 
Limitations:  low number of participants, 
testing the healthiest VLBW, unblended, 
limited ability to generalize.  
 
Recommendations:  common sense 
interventions from a bone physiology 
perspective; blinded randomized RCT’s 
with large numbers needed to confirm 
results and refine interventions 
Limitations:  study not specifically geared 
to premature; unknown parameters such 
as average number of day on the study of 
each group, low number of participants 
 
Recommendations:  common sense 
interventions from a bone physiology 
perspective; questionable relevance 
without knowing average gestational age 
of cohorts 
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Table 2 
AUTHOR (YEAR)  
JOURNAL 
STUDY LOCATION 
Litmanovitz et al (2003) 
Pediatrics 
Meir General Hospital, Kfar Saba, Israel 
Litmanovitz et al (2006) 
Calcif Tissue Int 
Meir Medical Center, Kfar Saba, Israel 
DESIGN  
 
 
COHORT 
 
 
# OF SUBJECTS 
Randomized clinical trial; data collected for 
four weeks 
 
BW: < 1500 gr, AGA 
PNA: < 1 wk 
 
n=12 each EX & C groups 
Randomized clinical trial; data collected 
for eight weeks 
 
BW: < 1500 gr, AGA 
PNA: < 1 wk 
 
n=8 each EX & C groups 
INTERVENTIONS  
OF STUDY 
EX group:  ROM to four extremities, 5 
repetitions each movement once daily, five 
time per week x4 wks  
 
C group: 5 minutes per day of focused 
holding/stroking, QD, 5x/week, x4 wks 
EX group:  ROM to four extremities, 5 
repetitions each movement once daily, 
five time per week x8 wks 
 
C group:  5 minutes per day of focused 
holding/stroking, QD, 5x/week, x8 wks 
RESULTS EX group: 
-no difference in initial or ending growth 
parameters (wt, lgt, OFC) vs. C group 
-stable tibial SOS vs. decreased in C group 
-no difference in biomarkers of bone 
turnover 
EX group: 
-no change in tibial SOS although C group 
showed significant decrease 
-increased BSAP and decreased ICTP 
were not significantly greater than C group 
-most gains occurred in first four weeks 
LIMITATIONS 
 
 
 
 
RECOMMENDATIONS 
Limitations:  low number of subjects, not 
blinded,  
 
Recommendations:   blinded randomized 
RCT’s with large numbers needed 
specifically to study younger, more 
unstable VLBW such as these participants 
Limitations:  low number of subjects, not 
blinded 
 
Recommendations:  blinded randomized 
RCT’s with large numbers needed 
specifically to study younger, more 
unstable VLBW such as these participants 
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Table 3 
AUTHOR (YEAR)  
JOURNAL 
STUDY LOCATION 
Moyer-Mileur, Ball, Brunstetter, & Chan, 2008 
Journal of Perinatology 
University Hospital, Salt Lake City 
DESIGN  
 
 
COHORT 
 
 
 
# OF SUBJECTS 
Randomized clinical trial 
 
BW:  800-1550 gr 
CGA:  26-31 weeks, AGA 
Enteral feeds: <110 kcal/kg/day of breastmilk 
fortified to 24 cal/oz 
Medications: none other than vitamin supplements 
n=11 each group MOM/OT/C 
INTERVENTIONS  
OF STUDY 
MOM: ROM to all extremities by the mother, five repetitions each daily until neonate 
reaches 2kg in weight 
OT: ROM to all extremities by the OT, five repetitions each daily until neonate reaches 
2kg in weight 
C group:  focused touch/stroking, five minutes per day, daily until neonate reaches 
2kg in weight 
 
RESULTS -final body weight higher in MOM/OT groups, but daily rate of wt. gain no different vs. 
C group 
-MOM/OT groups exhibited greater forearm bone area at 2kg; also had greater gains 
in bone area and bone mineral content by 2kg 
-no difference in serum and urine biomarkers for bone turnover vs. C group 
-no difference in results between MOM group and OT group 
LIMITATIONS 
 
 
RECOMMENDATIONS 
Limitations:  small numbers in study make it difficult to generalize, lacks joint 
compression component, not blinded 
 
Recommendations:  large number, double-blinded RCT’s are needed to properly 
research outcomes and establish outcome-based interventions. 
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